
Party at BIO conference that featured topless dancers draws fire from organization
One attendee called the PABNAB party entertainment "tone-deaf," but it's not the first event of its kind at a biotech show.
One attendee called the PABNAB party entertainment "tone-deaf," but it's not the first event of its kind at a biotech show.
The Gates Medical Research Institute will develop products for malaria, tuberculosis, enteric and diarrheal diseases.
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Many issues around CAR-T remain to be hashed out, but many experts pointed to infrastructure and clinics' capabilities as crucial.
The company plans to open its upcoming trial of a Chinese-developed CAR-T at four initial sites later this year.
FDA commissioner gives clues of agency's right-to-try strategy in Q&A session during chat with BIO President Jim Greenwood.
CAR-Ts have generated excitement, but bispecific monoclonal antibodies may continue to have a competitive edge in some cases.